Fat dissolving treatments are generally well-tolerated by most individuals, with minimal discomfort experienced during the procedure
If tirzepatide is affecting your sleep, consider timing your injection to minimize nighttime disruption

Historically, the Centers for Medicare & Medicaid Services (CMS) required companies to show a meaningful difference between various plan offerings to avoid having nearly identical plans in a market, to ensure a proper balance between affording beneficiaries a wide range of plan choices and avoiding undue beneficiary confusion in making coverage selections.[ix] Under that standard, CMS only approved MA organization bids if they were substantially different from those of other plans offered by the organization in the area with respect to key plan characteristics such as premiums, cost sharing, or benefits offered.[x] The agency noted that [r]esearch studies indicate that consumers, especially elderly consumers, may be challenged by a large number of plan choices that may: (1) result in not making a choice, (2) create a bias to not change plans, and (3) impact MA enrollment growth.[xi] Nevertheless, in 2019, CMS eliminated the meaningful difference requirement,[xii] arguing that doing so would promote competition, innovation, available benefit offerings, and provide beneficiaries with affordable plans that are tailored for their unique health care needs and financial situation.[xiii] They noted at that time that they expect[] organizations to continue designing plan benefit packages that, within a service area, are different from one another with respect to key benefit design characteristics, so that any potential beneficiary confusion is minimized when comparing multiple plans offered by the organization.[xiv] In theory, plans would still be distinct

Hum Exp Toxicol